These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 19276748)

  • 1. Proteasome inhibition promotes functional recovery after peripheral nerve reperfusion injury.
    Park JW; Kim KM; Oh KJ; Rhyu IJ; Jang HS
    J Trauma; 2009 Mar; 66(3):743-8. PubMed ID: 19276748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of exogenous nitric oxide donor on motor functional recovery of reperfused peripheral nerve.
    Park JW; Qi WN; Cai Y; Nunley JA; Urbaniak JR; Chen LE
    J Hand Surg Am; 2005 May; 30(3):519-27. PubMed ID: 15925162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteasome inhibition: mechanism of action.
    DeMartino GN
    J Natl Compr Canc Netw; 2004 Nov; 2 Suppl 4():S5-9. PubMed ID: 19791423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteasome inhibition attenuates hepatic injury in the bile duct-ligated mouse.
    Anan A; Baskin-Bey ES; Isomoto H; Mott JL; Bronk SF; Albrecht JH; Gores GJ
    Am J Physiol Gastrointest Liver Physiol; 2006 Oct; 291(4):G709-16. PubMed ID: 16798723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of inducible nitric oxide synthase promotes recovery of motor function in rats after sciatic nerve ischemia and reperfusion.
    Shin SJ; Qi WN; Cai Y; Rizzo M; Goldner RD; Nunley JA; Chen LE
    J Hand Surg Am; 2005 Jul; 30(4):826-35. PubMed ID: 16039380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-1 beta promotes functional recovery of crushed peripheral nerve.
    Korompilias AV; Chen LE; Seaber AV; Urbaniak JR
    J Orthop Res; 1999 Sep; 17(5):714-9. PubMed ID: 10569481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteasome inhibitor attenuates skeletal muscle reperfusion injury by blocking the pathway of nuclear factor-kappaB activation.
    Park JW; Qi WN; Cai Y; Urbaniak JR; Chen LE
    Plast Reconstr Surg; 2007 Dec; 120(7):1808-1818. PubMed ID: 18090742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduction of skeletal muscle atrophy by a proteasome inhibitor in a rat model of denervation.
    Beehler BC; Sleph PG; Benmassaoud L; Grover GJ
    Exp Biol Med (Maywood); 2006 Mar; 231(3):335-41. PubMed ID: 16514182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergistic interaction of the histone deacetylase inhibitor SAHA with the proteasome inhibitor bortezomib in mantle cell lymphoma.
    Heider U; von Metzler I; Kaiser M; Rosche M; Sterz J; Rötzer S; Rademacher J; Jakob C; Fleissner C; Kuckelkorn U; Kloetzel PM; Sezer O
    Eur J Haematol; 2008 Feb; 80(2):133-42. PubMed ID: 18005386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peripheral nerve ischemia: reperfusion injury and fiber regeneration.
    Iida H; Schmelzer JD; Schmeichel AM; Wang Y; Low PA
    Exp Neurol; 2003 Dec; 184(2):997-1002. PubMed ID: 14769393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ischemic preconditioning prevents skeletal muscle tissue injury, but not nerve lesion upon tourniquet-induced ischemia.
    Schoen M; Rotter R; Gierer P; Gradl G; Strauss U; Jonas L; Mittlmeier T; Vollmar B
    J Trauma; 2007 Oct; 63(4):788-97. PubMed ID: 18090007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The proteasome inhibitor bortezomib aggravates renal ischemia-reperfusion injury.
    Huber JM; Tagwerker A; Heininger D; Mayer G; Rosenkranz AR; Eller K
    Am J Physiol Renal Physiol; 2009 Aug; 297(2):F451-60. PubMed ID: 19458122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteasomal inhibition in intracerebral hemorrhage: neuroprotective and anti-inflammatory effects of bortezomib.
    Sinn DI; Lee ST; Chu K; Jung KH; Kim EH; Kim JM; Park DK; Song EC; Kim BS; Yoon SS; Kim M; Roh JK
    Neurosci Res; 2007 May; 58(1):12-8. PubMed ID: 17328981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteasome inhibition with bortezomib depletes plasma cells and autoantibodies in experimental autoimmune myasthenia gravis.
    Gomez AM; Vrolix K; Martínez-Martínez P; Molenaar PC; Phernambucq M; van der Esch E; Duimel H; Verheyen F; Voll RE; Manz RA; De Baets MH; Losen M
    J Immunol; 2011 Feb; 186(4):2503-13. PubMed ID: 21239719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteasome inhibitor bortezomib promotes a rupture-prone plaque phenotype in ApoE-deficient mice.
    Van Herck JL; De Meyer GR; Martinet W; Bult H; Vrints CJ; Herman AG
    Basic Res Cardiol; 2010 Jan; 105(1):39-50. PubMed ID: 19693627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteasome inhibitor lactacystin ablates liver injury induced by intestinal ischaemia-reperfusion.
    Yao JH; Li YH; Wang ZZ; Zhang XS; Wang YZ; Yuan JC; Zhou Q; Liu KX; Tian XF
    Clin Exp Pharmacol Physiol; 2007 Nov; 34(11):1102-8. PubMed ID: 17880361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of embolic stroke in rats with bortezomib and recombinant human tissue plasminogen activator.
    Zhang L; Zhang ZG; Liu X; Hozeska A; Stagliano N; Riordan W; Lu M; Chopp M
    Thromb Haemost; 2006 Jan; 95(1):166-73. PubMed ID: 16543976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteasome inhibition drastically but reversibly impairs murine lymphocyte development.
    Maseda D; Meister S; Neubert K; Herrmann M; Voll RE
    Cell Death Differ; 2008 Mar; 15(3):600-12. PubMed ID: 18188168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BCL-2 family regulation by the 20S proteasome inhibitor bortezomib.
    Fennell DA; Chacko A; Mutti L
    Oncogene; 2008 Feb; 27(9):1189-97. PubMed ID: 17828309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postconditioning protects skeletal muscle from ischemia-reperfusion injury.
    Park JW; Kang JW; Jeon WJ; Na HS
    Microsurgery; 2010; 30(3):223-9. PubMed ID: 20091882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.